Resonant Capital Advisors, LLC Amgen Inc Transaction History

Resonant Capital Advisors, LLC

$1.34 Billion
Q3 2024

A detailed history of Resonant Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 12,222 shares of AMGN stock, worth $3.42 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

12,222

Previous 12,133 0.73%

Holding current value

$3.42 Million

Previous $3.79 Million 3.91%

% of portfolio

0.29%

Previous 0.31%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $27,534 - $30,026	89 Added 0.73%	12,222 $3.94 Million
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $127,959 - $155,503	487 Added 4.18%	12,133 $3.79 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $19,627 - $23,692	73 Added 0.63%	11,646 $3.31 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $274,366 - $309,517	-1,073 Reduced 8.48%	11,573 $3.33 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $61,440 - $76,280	281 Added 2.27%	12,646 $3.4 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $69,423 - $82,091	-324 Reduced 2.55%	12,365 $2.75 Million
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $44,480 - $54,214	197 Added 1.58%	12,689 $3.07 Million
Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $22,673 - $28,809	99 Added 0.8%	12,492 $0
Q3 2022 Oct 20, 2022	BUY	$224.46 - $253.15 $17,283 - $19,492	77 Added 0.63%	12,393 $2.79 Million
Q2 2022 Jul 12, 2022	BUY	$230.71 - $256.74 $43,142 - $48,010	187 Added 1.54%	12,316 $3 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $187,256 - $207,154	854 Added 7.57%	12,129 $2.95 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $362,558 - $414,914	1,823 Added 19.29%	11,275 $2.54 Million
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $307,579 - $360,366	1,449 Added 18.11%	9,452 $2.01 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $51,154 - $56,751	219 Added 2.81%	8,003 $1.95 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $182,853 - $213,086	824 Added 11.84%	7,784 $1.94 Million
Q4 2020 Jan 15, 2021	BUY	$216.38 - $257.67 $139,997 - $166,712	647 Added 10.25%	6,960 $1.6 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $27,454 - $30,531	-117 Reduced 1.82%	6,313 $1.61 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $451,600 - $554,175	-2,283 Reduced 26.2%	6,430 $1.52 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $193,174 - $256,202	1,060 Added 13.85%	8,713 $1.77 Million
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $1.45 Million - $1.86 Million	7,653 New	7,653 $1.85 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.

Account

Resonant Capital Advisors, LLC Amgen Inc Transaction History